Cholera Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030

Cholera Vaccine Trends and Forecast

The future of the global cholera vaccine market looks promising with opportunities in the hospitals and clinics and research and academic laboratories markets. The global cholera vaccine market is expected to reach an estimated $155.38 billion by 2030 with a CAGR of 9.0% from 2024 to 2030. The major drivers for this market are growing awareness and efforts towards cholera prevention and government-driven initiatives and global collaborations are fostering collective action and progress towards common goals.

A more than 150-page report is developed to help in your business decisions.

Cholera Vaccine by Segment

The study includes a forecast for the global cholera vaccine by vaccine type, product, end use industry, and region.

Cholera Vaccine Market by Vaccine Type [Shipment Analysis by Value from 2018 to 2030]:

• Whole Cell V. Cholerae O1 with Recombinant B-Subunit
• Killed Oral O1 and O139

Cholera Vaccine Market by Product [Shipment Analysis by Value from 2018 to 2030]:

• Dukoral
• Shanchol
• Vaxchora
• Euvichol and Euvichol-Plus

Cholera Vaccine Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals and Clinics
• Research and Academic Laboratories
• Others

Cholera Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Cholera Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cholera vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cholera vaccine companies profiled in this report include-

• Astellas Pharma
• Celldex Therapeutics
• Emergent Biosolutions
• Eubiologics
• Johnson & Johnson
• Merck
• Pfizer
• Pharmachoice Canada
• Sanofi
• Takeda Pharmaceutical Company Limited

Cholera Vaccine Market Insights

Lucintel forecasts that whole cell v. cholerae O1 with recombinant b-subunit is expected to witness highest growth over the forecast period.

Within this market, hospitals and clinics will remain the largest segment.

North America is expected to witness highest growth over the forecast period.

Features of the Global Cholera Vaccine Market

Market Size Estimates: Cholera vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Cholera vaccine market size by vaccine type, product, end use industry, and region in terms of value ($B).

Regional Analysis: Cholera vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different vaccine type, product, end use industry, and regions for the cholera vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cholera vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the cholera vaccine market size?

Answer: The global cholera vaccine market is expected to reach an estimated $155.38 billion by 2030.

Q.2 What is the growth forecast for cholera vaccine market?

Answer: The global cholera vaccine market is expected to grow with a CAGR of 9.0% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the cholera vaccine market?

Answer: The major drivers for this market are growing awareness and efforts towards cholera prevention and government-driven initiatives and global collaborations are fostering collective action and progress towards common goals.

Q4. What are the major segments for cholera vaccine market?

Answer: The future of the cholera vaccine market looks promising with opportunities in the hospitals and clinics and research and academic laboratories markets.

Q5. Who are the key cholera vaccine market companies?

Answer: Some of the key cholera vaccine companies are as follows.

• Astellas Pharma
• Celldex Therapeutics
• Emergent BioSolutions
• Eubiologics
• Johnson & Johnson
• Merck
• Pfizer
• PharmaChoice Canada
• Sanofi
• Takeda Pharmaceutical Company Limited

Q6. Which cholera vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that whole cell v. cholerae O1 with recombinant b-subunit is expected to witness highest growth over the forecast period.

Q7. In cholera vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the cholera vaccine market by vaccine type (whole cell V. cholerae O1 with recombinant B-subunit and killed oral O1 and O139), product (dukoral, shanchol, vaxchora, euvichol and euvichol-plus, and others), end use industry (hospitals and clinics, research and academic laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?